Trends in Human Fecal Carriage of Extended-Spectrum β-Lactamases in the Community: Toward the Globalization of CTX-M

Clinical Microbiology Reviews - Tập 26 Số 4 - Trang 744-758 - 2013
Paul‐Louis Woerther1, Charles Burdet2,3, Élisabeth Chachaty1, Antoine Andremont3
1Institut Gustave Roussy, Laboratoire de Microbiologie, Villejuif, France
2Département de Biostatistiques, Hôpital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris, Paris, France
3Laboratoire de Bacteriologie, Hôpital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris, and EA3964 Université Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine, Paris, France

Tóm tắt

SUMMARY In the last 10 years, extended-spectrum β-lactamase-producing enterobacteria (ESBL-E) have become one of the main challenges for antibiotic treatment of enterobacterial infections, largely because of the current CTX-M enzyme pandemic. However, most studies have focused on hospitalized patients, though today it appears that the community is strongly affected as well. We therefore decided to devote our investigation to trends in ESBL-E fecal carriage rates and comprehensively reviewed data from studies conducted on healthy populations in various parts of the world. We show that (i) community ESBL-E fecal carriage, which was unknown before the turn of the millennium, has since increased significantly everywhere, with developing countries being the most affected; (ii) intercontinental travel may have emphasized and globalized the issue; and (iii) CTX-M enzymes, especially CTX-M-15, are the dominant type of ESBL. Altogether, these results suggest that CTX-M carriage is evolving toward a global pandemic but is still insufficiently described. Only a better knowledge of its dynamics and biology will lead to further development of appropriate control measures.

Từ khóa


Tài liệu tham khảo

10.1007/BF01641355

10.1128/AAC.35.9.1697

10.1128/AAC.28.2.302

10.1128/AAC.34.2.219

10.1007/BF01650727

10.1093/jac/27.4.441

10.1093/jac/dki166

10.1128/AAC.01009-09

10.1038/nrmicro2298

10.1128/AAC.40.2.509

10.3389/fmicb.2012.00110

10.1093/jac/dkn428

10.2807/ese.13.47.19044-en

10.1093/cid/ciq257

10.1093/jac/dks301

10.3855/jidc.454

10.1186/2047-2994-1-39

10.1086/422002

10.1128/iai.28.3.981-990.1980

10.1007/BF02930963

10.3201/eid0908.030094

10.1093/jac/dkq008

10.1016/j.jinf.2012.02.004

10.1128/AEM.00711-10

10.1093/jac/dkr363

10.1016/j.watres.2009.11.052

10.1093/jac/dkr564

10.1111/j.1365-2672.2011.05072.x

10.1007/s10096-012-1669-8

10.1111/j.1469-0691.2012.03930.x

10.1128/AEM.00054-13

10.1093/jac/dkq472

10.1016/j.envpol.2010.03.023

10.1007/s12275-008-0150-y

10.1128/AEM.00359-12

10.3109/00365548.2012.717712

10.1264/jsme2.ME11266

10.1128/AEM.07320-11

10.1128/CMR.00002-11

10.1186/1746-6148-8-21

10.1016/j.healthpol.2005.09.009

10.1093/cid/cis929

10.1111/j.1469-0691.2011.03497.x

10.1093/jac/dkh444

10.1128/AAC.01701-09

10.1111/j.1469-0691.2010.03127.x

10.1016/j.vetmic.2012.10.029

10.1093/jac/dkq004

10.1128/AAC.00306-11

10.1128/JCM.01581-09

10.1128/AAC.02622-12

10.1016/S0924-8579(99)00165-X

10.1007/s10096-006-0242-8

10.1128/JCM.42.10.4769-4775.2004

10.1093/jac/dkl211

10.1093/jac/dki395

10.1093/jac/dkn293

10.1128/JCM.01008-08

10.1089/mdr.2009.0910

10.1111/j.1469-0691.2010.03340.x

10.1016/j.patbio.2010.07.012

10.1128/JCM.00734-08

10.1093/jac/dkh397

10.1007/s10096-011-1202-5

10.1128/AAC.05539-11

10.1093/jac/dkm464

10.1007/s10096-011-1313-z

10.1093/jac/dks018

10.1093/jac/dks429

10.1128/JCM.43.7.3309-3313.2005

10.1007/s10096-011-1471-z

10.2310/JIM.0b013e318238748e

10.1128/AAC.00139-09

10.1093/cid/cir522

10.1371/journal.pone.0022738

10.1186/1471-2334-10-204

10.1111/j.1365-3156.2011.02949.x

10.1093/jac/dks118

10.1099/jmm.0.026955-0

10.3109/00365548.2010.538856

10.1139/W08-059

10.1128/AAC.00026-07

10.1128/AAC.48.12.4556-4561.2004

10.1111/j.1469-0691.2012.03807.x

10.1086/654883

10.1371/journal.pone.0045141

10.1016/j.diagmicrobio.2010.10.029

10.1128/AAC.34.4.515

10.1093/jac/dkr041

10.3109/00365540903493715

10.1128/AAC.00220-10

10.1111/j.1708-8305.2011.00548.x

10.1007/s10096-012-1584-z

10.1016/j.ajic.2012.05.015

10.3109/00365548.2011.653582

10.1093/jac/dkq068

10.1128/AAC.46.1.151-159.2002

10.1016/j.jinf.2010.02.002

10.1016/j.ajic.2010.09.018

10.1371/journal.pone.0062678

10.1016/j.ajic.2011.11.008

10.1111/j.1600-0463.2007.apm_547.x

10.1128/AAC.05103-11

10.1016/j.ajic.2006.09.011

10.1016/j.jhin.2006.06.014

10.1128/AAC.00009-11

10.1016/j.ajic.2007.10.007

10.1086/597090

Cantey JB Sreeramoju P Jaleel M Trevino S Gander R Hynan LS Hill J Brown C Chung W Siegel JD Sanchez PJ . Prompt control of an outbreak caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. J. Pediatr., in press.

10.1016/j.jhin.2006.12.014

10.1017/S0950268809990409

10.1093/cid/cis770

WHO. 2013. Water quality and health strategy 2013–2020. WHO, Geneva, Switzerland. http://www.who.int/water_sanitation_health/publications/2013/water_quality_strategy.pdf . Accessed 3 June 2013.

10.1016/j.scitotenv.2013.01.032

Prado T Pereira WC Silva DM Seki LM Carvalho AP Asensi MD . 2008. Detection of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in effluents and sludge of a hospital sewage treatment plant. Lett. Appl. Microbiol. 46:136–141.

10.1016/j.copbio.2008.05.006

European Parliament and the Council of the European Union. 2008. Directive 2008/105/EC of the European Parliament and of the Council. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2008:348:0084:0097:EN:PDF . Accessed 3 June 2013.

10.1086/600122

Pitout JD . 2009. IPSAT P1A, a class A beta-lactamase therapy for the prevention of penicillin-induced disruption to the intestinal microflora. Curr. Opin. Invest. Drugs 10:838–844.

10.1016/j.ejps.2010.06.018

10.1016/S1473-3099(12)70322-5

10.1086/663206

Huttner B Haustein T Uçkay I Renzi G Stewardson A Schaerrer D Agostinho A Andremont A Schrenzel J Pittet D Harbarth S . Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial. J. Antimicrob. Chemother., in press.

10.1099/jmm.0.025874-0

10.1016/S1473-3099(10)70227-9

10.1186/1471-2458-10-545

10.1016/S0140-6736(05)66912-7

10.1001/jama.291.21.2547

10.1371/journal.pmed.1001052

10.1128/AAC.48.10.3758-3764.2004

10.1128/JCM.01542-07

Datta N Dacey S Hughes V Knight S Richards H Williams G Casewell M Shannon KP . 1980. Distribution of genes for trimethoprim and gentamicin resistance in bacteria and their plasmids in a general hospital. J. Gen. Microbiol. 118:495–508.

10.1038/208239a0

10.1007/BF02276062

10.1016/0924-8579(94)90053-1

10.1017/S0950268800058374

10.1017/S0950268800056922

10.1128/am.25.1.21-23.1973

10.1093/infdis/130.3.274

10.1128/AAC.3.2.175

10.1128/aem.45.1.79-83.1983

10.1128/AAC.6.6.697

10.3389/fmicb.2012.00083

10.1086/500936

10.1111/j.1469-0691.2009.02803.x

10.1007/s15010-012-0324-8

10.1086/519865

Kader AA Kamath KA . 2009. Faecal carriage of extended-spectrum beta-lactamase-producing bacteria in the community. East Mediterr. Health J. 15:1365–1370.

10.1186/1471-2334-12-53

Ho PL Wong RC Chow KH Yip K Wong SS Que TL . 2008. CTX-M type beta-lactamases among fecal Escherichia coli and Klebsiella pneumoniae isolates in non-hospitalized children and adults. J. Microbiol. Immunol. Infect. 41:428–432.

10.1007/s10156-011-0225-2

10.1007/s15010-012-0272-3

10.1128/AAC.01101-06

Thông tin
Thông tin xuất bản

Clinical Microbiology Reviews

Tập 26 Số 4

744-758

Thông tin tác giả